Kelli Stidham Hall1, James Trussell. 1. Office of Population Research, Princeton University, Princeton, NJ 08544, USA. kshall@princeton.edu
Abstract
BACKGROUND: We sought to estimate the prevalence of types of combined oral contraceptives (COCs) used among US women. STUDY DESIGN: We analyzed interview-collected data from 12,279 women aged 15-44 years participating in the National Survey of Family Growth, 2006-2010. Analyses focused on COC use overall, by pill type, across sociodemographics and health factors. RESULTS: The prevalence of current COC use (88 different brands) was 17%. The majority of COC users used earlier-formulation COCs: ≥30 mcg (67%) versus <30 mcg estrogen (33%), monophasic (67%) versus multiphasic (33%) dosages and traditional 21/7 (88%) versus extended/other cycle regimens (12%) regimens. Norgestimate (32%) and norethindrone (20%) were the most commonly used progestins. Sociodemographic, gynecological and health risk factors were associated with type of COC use. CONCLUSION: Further investigation of specific COC use and of the factors associated with types of pills used among US women at the population level is needed.
BACKGROUND: We sought to estimate the prevalence of types of combined oral contraceptives (COCs) used among US women. STUDY DESIGN: We analyzed interview-collected data from 12,279 women aged 15-44 years participating in the National Survey of Family Growth, 2006-2010. Analyses focused on COC use overall, by pill type, across sociodemographics and health factors. RESULTS: The prevalence of current COC use (88 different brands) was 17%. The majority of COC users used earlier-formulation COCs: ≥30 mcg (67%) versus <30 mcg estrogen (33%), monophasic (67%) versus multiphasic (33%) dosages and traditional 21/7 (88%) versus extended/other cycle regimens (12%) regimens. Norgestimate (32%) and norethindrone (20%) were the most commonly used progestins. Sociodemographic, gynecological and health risk factors were associated with type of COC use. CONCLUSION: Further investigation of specific COC use and of the factors associated with types of pills used among US women at the population level is needed.
Authors: Theresa A Lawrie; Frans M Helmerhorst; Nandita K Maitra; Regina Kulier; Kitty Bloemenkamp; A Metin Gülmezoglu Journal: Cochrane Database Syst Rev Date: 2011-05-11
Authors: Alicia M Allen; Andrea H Weinberger; Reagan R Wetherill; Carol L Howe; Sherry A McKee Journal: Nicotine Tob Res Date: 2019-04-17 Impact factor: 4.244
Authors: Jennifer Cheng; Kristen A Santiago; Zafir Abutalib; Kate E Temme; Ann Hulme; Marci A Goolsby; Carrie L Esopenko; Ellen K Casey Journal: PM R Date: 2020-12-19 Impact factor: 2.298
Authors: Ida Martinelli; Anthonie W A Lensing; Saskia Middeldorp; Marcel Levi; Jan Beyer-Westendorf; Bonno van Bellen; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Mila Trajanovic; Martin Gebel; Phuong Lam; Philip S Wells; Martin H Prins Journal: Blood Date: 2015-12-22 Impact factor: 22.113
Authors: Leslie Spangler; Laura E Ichikawa; Rebecca A Hubbard; Belinda Operskalski; Andrea Z LaCroix; Susan M Ott; Delia Scholes Journal: Ann Epidemiol Date: 2014-10-16 Impact factor: 3.797